Ligatoxin-B

General Information


DRACP ID  DRACP00047

Peptide Name   Ligatoxin-B

Sequence  KSCCPSTTARNIYNTCRLTGASRSVCASLSGCKIISGSTCDSGWNH

Sequence Length  46

UniProt ID  Not available

PubChem CID  Not available

Origin  Phoradendron liga

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
U-937/GTB Adult acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia IC50=1.8 µM FMCA assay 72h 1
ACHN Papillary renal cell carcinoma Carcinoma IC50=3.2 µM FMCA assay 72h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00047

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3<--->Cys40; Cys4<--->Cys32; Cys16<---Cys26

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C194H319N63O67S6

Absent amino acids  EFMQ

Common amino acids  S

Mass  560124

Pl  8.63

Basic residues  6

Acidic residues  1

Hydrophobic residues  10

Net charge  5

Boman Index  -8491

Hydrophobicity  -19.35

Aliphatic Index  55.22

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  7365

Absorbance 280nm  163.67

Polar residues  28

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12049612

Title  Ligatoxin B, a new cytotoxic protein with a novel helix-turn-helix DNA-binding domain from the mistletoe Phoradendron liga

Doi 10.1042/BJ20020221

Year  2002

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.